1. Consensus Recommendations on GLP-1 RA Use in the Management of Type 2 Diabetes Mellitus: South Asian Task Force
   Sanjay Kalra et al, 2019, Diabetes Ther CrossRef
2. GLP‐1 agonists for obesity and type 2 diabetes in children: Systematic review and meta‐analysis
   Karan R. Chadda et al, 2020, Obesity Reviews CrossRef
3. Safety and Efficacy of GLP-1 Receptor Agonists in Children and Adolescents with Obesity: A Meta-Analysis
   Paul M. Ryan et al, 2021, The Journal of Pediatrics CrossRef
4. Liraglutide suppresses obesity and promotes browning of white fat via miR-27b in vivo and in vitro
   Xing Wang et al, 2021, J Int Med Res CrossRef
5. Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity
   Mojca Jensterle et al, 2021, Horm Res Paediatr CrossRef
6. Efficacy and safety of liraglutide for weight management in children and adolescents: a systematic review and meta-analysis of randomized controlled trials
   Hao Gou et al, 2023, Eur J Pediatr CrossRef
7. The effects of incretin‐based therapies on weight reduction and metabolic parameters in children with obesity: A systematic review and meta‐analysis
   Jian‐Ying Wang et al, 2024, Obesity Reviews CrossRef
8. Efficacy and safety of glucagon-like peptide-1 receptor agonists on prediabetes: a systematic review and meta-analysis of randomized controlled trials
   Hazem Mohamed Salamah et al, 2024, Diabetol Metab Syndr CrossRef